Financhill
Buy
66

XTNT Quote, Financials, Valuation and Earnings

Last price:
$0.69
Seasonality move :
-0.13%
Day range:
$0.66 - $0.73
52-week range:
$0.33 - $0.83
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.83x
P/B ratio:
2.34x
Volume:
89.2K
Avg. volume:
349.7K
1-year change:
-4.01%
Market cap:
$102.7M
Revenue:
$117.3M
EPS (TTM):
-$0.09

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
XTNT
Xtant Medical Holdings
$31.2M -$0.01 4.73% -33.33% $1.75
CATX
Perspective Therapeutics
$143.9K -$0.27 -- -55.87% $13.8214
INFU
InfuSystems Holdings
$33.8M -$0.03 6.95% 33.33% $14.13
RVP
Retractable Technologies
-- -- -- -- --
VNRX
VolitionRX
$1.1M -$0.05 6.24% -40.63% $2.92
VTAK
Catheter Precision
$310K -$0.20 118.75% -11.57% --
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
XTNT
Xtant Medical Holdings
$0.74 $1.75 $102.7M -- $0.00 0% 0.83x
CATX
Perspective Therapeutics
$2.3900 $13.8214 $177.4M -- $0.00 0% 16.84x
INFU
InfuSystems Holdings
$5.41 $14.13 $113.5M 38.64x $0.00 0% 0.85x
RVP
Retractable Technologies
$0.65 -- $19.4M -- $0.00 0% 0.58x
VNRX
VolitionRX
$0.52 $2.92 $53.1M -- $0.00 0% 35.53x
VTAK
Catheter Precision
$0.24 -- $2.6M 0.40x $0.00 0% 2.76x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
XTNT
Xtant Medical Holdings
43.24% -0.806 51.14% 0.96x
CATX
Perspective Therapeutics
-- -1.032 -- --
INFU
InfuSystems Holdings
34.23% 3.691 25.44% 1.59x
RVP
Retractable Technologies
1.48% -0.347 12.06% 4.40x
VNRX
VolitionRX
-29.91% 1.111 11.38% 0.34x
VTAK
Catheter Precision
17.75% -1.682 53.57% 0.13x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
XTNT
Xtant Medical Holdings
$20.2M $1.1M -15.44% -26.62% 3.28% $87K
CATX
Perspective Therapeutics
-- -$21.8M -- -- -- -$26.2M
INFU
InfuSystems Holdings
$19.2M $618K 3.81% 5.82% 1.7% -$1.6M
RVP
Retractable Technologies
-$1.9K -$3.2M -25.99% -26.39% -122.86% -$1.6M
VNRX
VolitionRX
-- -$5.4M -- -- -2183.56% -$4.3M
VTAK
Catheter Precision
$132K -$3.5M -126.5% -137.84% -3300.7% -$2.3M

Xtant Medical Holdings vs. Competitors

  • Which has Higher Returns XTNT or CATX?

    Perspective Therapeutics has a net margin of 0.18% compared to Xtant Medical Holdings's net margin of --. Xtant Medical Holdings's return on equity of -26.62% beat Perspective Therapeutics's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    XTNT
    Xtant Medical Holdings
    61.52% -- $77.3M
    CATX
    Perspective Therapeutics
    -- -$0.25 --
  • What do Analysts Say About XTNT or CATX?

    Xtant Medical Holdings has a consensus price target of $1.75, signalling upside risk potential of 137.51%. On the other hand Perspective Therapeutics has an analysts' consensus of $13.8214 which suggests that it could grow by 478.3%. Given that Perspective Therapeutics has higher upside potential than Xtant Medical Holdings, analysts believe Perspective Therapeutics is more attractive than Xtant Medical Holdings.

    Company Buy Ratings Hold Ratings Sell Ratings
    XTNT
    Xtant Medical Holdings
    2 0 0
    CATX
    Perspective Therapeutics
    10 1 0
  • Is XTNT or CATX More Risky?

    Xtant Medical Holdings has a beta of -0.124, which suggesting that the stock is 112.425% less volatile than S&P 500. In comparison Perspective Therapeutics has a beta of 1.112, suggesting its more volatile than the S&P 500 by 11.175%.

  • Which is a Better Dividend Stock XTNT or CATX?

    Xtant Medical Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Perspective Therapeutics offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Xtant Medical Holdings pays -- of its earnings as a dividend. Perspective Therapeutics pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios XTNT or CATX?

    Xtant Medical Holdings quarterly revenues are $32.9M, which are larger than Perspective Therapeutics quarterly revenues of --. Xtant Medical Holdings's net income of $58K is higher than Perspective Therapeutics's net income of -$18.2M. Notably, Xtant Medical Holdings's price-to-earnings ratio is -- while Perspective Therapeutics's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Xtant Medical Holdings is 0.83x versus 16.84x for Perspective Therapeutics. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    XTNT
    Xtant Medical Holdings
    0.83x -- $32.9M $58K
    CATX
    Perspective Therapeutics
    16.84x -- -- -$18.2M
  • Which has Higher Returns XTNT or INFU?

    InfuSystems Holdings has a net margin of 0.18% compared to Xtant Medical Holdings's net margin of -0.77%. Xtant Medical Holdings's return on equity of -26.62% beat InfuSystems Holdings's return on equity of 5.82%.

    Company Gross Margin Earnings Per Share Invested Capital
    XTNT
    Xtant Medical Holdings
    61.52% -- $77.3M
    INFU
    InfuSystems Holdings
    55.21% -$0.01 $83.9M
  • What do Analysts Say About XTNT or INFU?

    Xtant Medical Holdings has a consensus price target of $1.75, signalling upside risk potential of 137.51%. On the other hand InfuSystems Holdings has an analysts' consensus of $14.13 which suggests that it could grow by 151.85%. Given that InfuSystems Holdings has higher upside potential than Xtant Medical Holdings, analysts believe InfuSystems Holdings is more attractive than Xtant Medical Holdings.

    Company Buy Ratings Hold Ratings Sell Ratings
    XTNT
    Xtant Medical Holdings
    2 0 0
    INFU
    InfuSystems Holdings
    4 0 0
  • Is XTNT or INFU More Risky?

    Xtant Medical Holdings has a beta of -0.124, which suggesting that the stock is 112.425% less volatile than S&P 500. In comparison InfuSystems Holdings has a beta of 1.729, suggesting its more volatile than the S&P 500 by 72.942%.

  • Which is a Better Dividend Stock XTNT or INFU?

    Xtant Medical Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. InfuSystems Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Xtant Medical Holdings pays -- of its earnings as a dividend. InfuSystems Holdings pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios XTNT or INFU?

    Xtant Medical Holdings quarterly revenues are $32.9M, which are smaller than InfuSystems Holdings quarterly revenues of $34.7M. Xtant Medical Holdings's net income of $58K is higher than InfuSystems Holdings's net income of -$267K. Notably, Xtant Medical Holdings's price-to-earnings ratio is -- while InfuSystems Holdings's PE ratio is 38.64x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Xtant Medical Holdings is 0.83x versus 0.85x for InfuSystems Holdings. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    XTNT
    Xtant Medical Holdings
    0.83x -- $32.9M $58K
    INFU
    InfuSystems Holdings
    0.85x 38.64x $34.7M -$267K
  • Which has Higher Returns XTNT or RVP?

    Retractable Technologies has a net margin of 0.18% compared to Xtant Medical Holdings's net margin of -126.59%. Xtant Medical Holdings's return on equity of -26.62% beat Retractable Technologies's return on equity of -26.39%.

    Company Gross Margin Earnings Per Share Invested Capital
    XTNT
    Xtant Medical Holdings
    61.52% -- $77.3M
    RVP
    Retractable Technologies
    -0.02% -$0.35 $77.8M
  • What do Analysts Say About XTNT or RVP?

    Xtant Medical Holdings has a consensus price target of $1.75, signalling upside risk potential of 137.51%. On the other hand Retractable Technologies has an analysts' consensus of -- which suggests that it could fall by --. Given that Xtant Medical Holdings has higher upside potential than Retractable Technologies, analysts believe Xtant Medical Holdings is more attractive than Retractable Technologies.

    Company Buy Ratings Hold Ratings Sell Ratings
    XTNT
    Xtant Medical Holdings
    2 0 0
    RVP
    Retractable Technologies
    0 0 0
  • Is XTNT or RVP More Risky?

    Xtant Medical Holdings has a beta of -0.124, which suggesting that the stock is 112.425% less volatile than S&P 500. In comparison Retractable Technologies has a beta of 1.650, suggesting its more volatile than the S&P 500 by 64.995%.

  • Which is a Better Dividend Stock XTNT or RVP?

    Xtant Medical Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Retractable Technologies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Xtant Medical Holdings pays -- of its earnings as a dividend. Retractable Technologies pays out -1.94% of its earnings as a dividend.

  • Which has Better Financial Ratios XTNT or RVP?

    Xtant Medical Holdings quarterly revenues are $32.9M, which are larger than Retractable Technologies quarterly revenues of $8.3M. Xtant Medical Holdings's net income of $58K is higher than Retractable Technologies's net income of -$10.5M. Notably, Xtant Medical Holdings's price-to-earnings ratio is -- while Retractable Technologies's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Xtant Medical Holdings is 0.83x versus 0.58x for Retractable Technologies. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    XTNT
    Xtant Medical Holdings
    0.83x -- $32.9M $58K
    RVP
    Retractable Technologies
    0.58x -- $8.3M -$10.5M
  • Which has Higher Returns XTNT or VNRX?

    VolitionRX has a net margin of 0.18% compared to Xtant Medical Holdings's net margin of -2201.34%. Xtant Medical Holdings's return on equity of -26.62% beat VolitionRX's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    XTNT
    Xtant Medical Holdings
    61.52% -- $77.3M
    VNRX
    VolitionRX
    -- -$0.06 -$22.6M
  • What do Analysts Say About XTNT or VNRX?

    Xtant Medical Holdings has a consensus price target of $1.75, signalling upside risk potential of 137.51%. On the other hand VolitionRX has an analysts' consensus of $2.92 which suggests that it could grow by 467.22%. Given that VolitionRX has higher upside potential than Xtant Medical Holdings, analysts believe VolitionRX is more attractive than Xtant Medical Holdings.

    Company Buy Ratings Hold Ratings Sell Ratings
    XTNT
    Xtant Medical Holdings
    2 0 0
    VNRX
    VolitionRX
    2 1 0
  • Is XTNT or VNRX More Risky?

    Xtant Medical Holdings has a beta of -0.124, which suggesting that the stock is 112.425% less volatile than S&P 500. In comparison VolitionRX has a beta of 0.997, suggesting its less volatile than the S&P 500 by 0.339%.

  • Which is a Better Dividend Stock XTNT or VNRX?

    Xtant Medical Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. VolitionRX offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Xtant Medical Holdings pays -- of its earnings as a dividend. VolitionRX pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios XTNT or VNRX?

    Xtant Medical Holdings quarterly revenues are $32.9M, which are larger than VolitionRX quarterly revenues of $246.4K. Xtant Medical Holdings's net income of $58K is higher than VolitionRX's net income of -$5.4M. Notably, Xtant Medical Holdings's price-to-earnings ratio is -- while VolitionRX's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Xtant Medical Holdings is 0.83x versus 35.53x for VolitionRX. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    XTNT
    Xtant Medical Holdings
    0.83x -- $32.9M $58K
    VNRX
    VolitionRX
    35.53x -- $246.4K -$5.4M
  • Which has Higher Returns XTNT or VTAK?

    Catheter Precision has a net margin of 0.18% compared to Xtant Medical Holdings's net margin of -2828.67%. Xtant Medical Holdings's return on equity of -26.62% beat Catheter Precision's return on equity of -137.84%.

    Company Gross Margin Earnings Per Share Invested Capital
    XTNT
    Xtant Medical Holdings
    61.52% -- $77.3M
    VTAK
    Catheter Precision
    92.31% -$0.36 $9.6M
  • What do Analysts Say About XTNT or VTAK?

    Xtant Medical Holdings has a consensus price target of $1.75, signalling upside risk potential of 137.51%. On the other hand Catheter Precision has an analysts' consensus of -- which suggests that it could grow by 733.68%. Given that Catheter Precision has higher upside potential than Xtant Medical Holdings, analysts believe Catheter Precision is more attractive than Xtant Medical Holdings.

    Company Buy Ratings Hold Ratings Sell Ratings
    XTNT
    Xtant Medical Holdings
    2 0 0
    VTAK
    Catheter Precision
    0 0 0
  • Is XTNT or VTAK More Risky?

    Xtant Medical Holdings has a beta of -0.124, which suggesting that the stock is 112.425% less volatile than S&P 500. In comparison Catheter Precision has a beta of -0.870, suggesting its less volatile than the S&P 500 by 187.02%.

  • Which is a Better Dividend Stock XTNT or VTAK?

    Xtant Medical Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Catheter Precision offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Xtant Medical Holdings pays -- of its earnings as a dividend. Catheter Precision pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios XTNT or VTAK?

    Xtant Medical Holdings quarterly revenues are $32.9M, which are larger than Catheter Precision quarterly revenues of $143K. Xtant Medical Holdings's net income of $58K is higher than Catheter Precision's net income of -$4M. Notably, Xtant Medical Holdings's price-to-earnings ratio is -- while Catheter Precision's PE ratio is 0.40x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Xtant Medical Holdings is 0.83x versus 2.76x for Catheter Precision. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    XTNT
    Xtant Medical Holdings
    0.83x -- $32.9M $58K
    VTAK
    Catheter Precision
    2.76x 0.40x $143K -$4M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Where Will Palo Alto Networks Stock Be in 5 Years?
Where Will Palo Alto Networks Stock Be in 5 Years?

You know those companies that just refuse to slow down…

UPS Stock Forecast: Is the 6.9% Dividend Too Good to Be True?
UPS Stock Forecast: Is the 6.9% Dividend Too Good to Be True?

Parcel delivery giant UPS (NYSE:UPS) has seen its fair share…

Where Will Coinbase Stock Be in 5 Years?
Where Will Coinbase Stock Be in 5 Years?

If you’ve been anywhere near the crypto world over the…

Stock Ideas

Buy
65
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 38x

Buy
65
Is NVDA Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 45x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Buy
55
SBET alert for May 27

SharpLink Gaming [SBET] is up 454.46% over the past day.

Buy
57
RGC alert for May 27

Regencell Bioscience Holdings [RGC] is down 9.77% over the past day.

Buy
90
OKLO alert for May 27

Oklo [OKLO] is up 10.05% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock